Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |